Category: Supply Chain

345 surgical kits flagged for possible sterility issues

Regard Operative Lap P&S Surgical Kits made by ROi CPS pose a risk of serious harm due to the possibility that some kits may not be sterile, the FDA said in a Jan. 16 notice. 

FDA faces federal probe over medical device oversight

The Government Accountability Office is launching a probe into the FDA’s oversight of medical device recalls, ProPublica reported Jan. 18.  

Medline's 9 hospital deals in 2023

In 2023, medical supply company Medline sealed nine agreements with health systems, including primary vendor partnerships and a collaboration to co-develop a new supply center in Florida.

Meet 9 women leaders in hospital supply chain

At the end of 2023, the Journal of Healthcare Contracting interviewed nine women supply leaders in the healthcare industry. 

Supply chain issues to monitor in 2024

As the healthcare supply chain continues to bounce back from COVID-19 disruptions, leaders are monitoring geopolitical concerns, inflation, artificial intelligence and cybersecurity dangers. 

Physicians want more premarket evidence from FDA, study says

More physicians understand the FDA’s approval process for drugs than they do for medical devices, according to findings from a survey published Jan. 16 in Health Affairs.

LifePoint supply chain leader moves to South Dakota system

Prairie Lakes Healthcare System named Michael Moore as its new supply chain director Jan. 12. 

20M CPAP masks might interfere with medical devices: FDA

There is a risk of serious injury or death related to more than 20 million CPAP masks made by ResMed, the FDA said Jan. 11. 

Medtronic to close manufacturing sites, distribution centers

Medtronic has ended contracts with 200 suppliers, and the medical device company plans to close five manufacturing plants and six distribution centers, according to a Jan. 9 Star Tribune report.

FDA to allow imports of syphilis drug amid shortage

The FDA has issued temporary authorization for the importation of a syphilis drug that’s been in short supply since last April.